Voskuil, Floris J. http://orcid.org/0000-0003-3740-4554
Vonk, Jasper
van der Vegt, Bert http://orcid.org/0000-0002-2613-1506
Kruijff, Schelto
Ntziachristos, Vasilis http://orcid.org/0000-0002-9988-0233
van der Zaag, Pieter J. http://orcid.org/0000-0001-9080-4907
Witjes, Max J. H.
van Dam, Gooitzen M. http://orcid.org/0000-0002-7248-8696
Article History
Received: 1 May 2019
Accepted: 17 June 2021
First Online: 8 November 2021
Competing interests
: B.v.d.V. is a member of the Scientific Advisory Board of Visiopharm, for which compensation is received by the University Medical Center Groningen. V.N. is an equity owner and consultant of iThera Medical GmbH, an owner of Spear UG and a member of the Scientific Advisory Board of SurgVision B.V./Bracco Sp.A. P.J.v.d.Z. is an employee of Philips Research, The Netherlands. G.M.v.D. is CEO, founder and shareholder of TRACER Europe BV/AxelaRx. The other authors declare no competing interests.